Decoding the dark proteome: Deep learning-enabled discovery of druggable enzymes in Wuchereria bancrofti
Wuchereria bancrofti, the parasitic roundworm responsible for lymphatic filariasis, permanently disables over 36 million people and places 657 million at risk across 39 countries. A major bottleneck for drug discovery is the lack of functional annotation for more than 90 percent of the W. bancrofti dark proteome, leaving many potential targets unidentified. In this work, we present a novel computational pipeline that converts W. bancrofti's unannotated amino acid sequence data into precise four-level Enzyme Commission (EC) numbers and drug candidates. We utilized a DEtection TRansformer to estimate the probability of enzymatic function, fine-tuned a hierarchical nearest neighbor EC predictor on 4,476 labeled parasite proteins, and applied rejection sampling to retain only four-level EC classifications at 100 percent confidence. This pipeline assigned precise EC numbers to 14,772 previously uncharacterized proteins and discovered 543 EC classes not previously known in W. bancrofti. A qualitative triage emphasizing parasite-specific targets, chemical tractability, biochemical importance, and biological plausibility prioritized six enzymes across five separate strategies: anti-Wolbachia cell-wall inhibition, proteolysis blockade, transmission disruption, purinergic immune interference, and cGMP-signaling destabilization. We curated a 43-compound library from ChEMBL and BindingDB and co-folded across multiple protein conformers with Boltz-2. All six targets exhibited at least moderately strong predicted binding affinities below 1 micromolar, with moenomycin analogs against peptidoglycan glycosyltransferase and NTPase inhibitors showing promising nanomolar hits and well-defined binding pockets. While experimental validation remains essential, our results provide the first large-scale functional map of the W. bancrofti dark proteome and accelerate early-stage drug development for the species.
Code (0)
등록된 구현이 없습니다.
Tasks
Drug DiscoverySimilar Papers 제목 키워드 기반
Accurate de novo sequencing of the modified proteome with OmniNovo
Post-translational modifications (PTMs) serve as a dynamic chemical language regulating protein function, yet current proteomic methods remain blind to a vast portion of the modified proteome. Standard database search al…
Exploration of Dark Chemical Genomics Space via Portal Learning: Applied to Targeting the Undruggable Genome and COVID-19 Anti-Infective Polypharmacology
Advances in biomedicine are largely fueled by exploring uncharted territories of human biology. Machine learning can both enable and accelerate discovery, but faces a fundamental hurdle when applied to unseen data with d…
BIG-bench Machine LearningMeta-LearningModel SelectionTransfer LearningLA4SR: illuminating the dark proteome with generative AI
AI language models (LMs) show promise for biological sequence analysis. We re-engineered open-source LMs (GPT-2, BLOOM, DistilRoBERTa, ELECTRA, and Mamba, ranging from 70M to 12B parameters) for microbial sequence classi…
MambaFitness aligned structural modeling enables scalable virtual screening with AuroBind
Most human proteins remain undrugged, over 96% of human proteins remain unexploited by approved therapeutics. While structure-based virtual screening promises to expand the druggable proteome, existing methods lack atomi…
Transcriptome and Redox Proteome Reveal Temporal Scales of Carbon Metabolism Regulation in Model Cyanobacteria Under Light Disturbance
We develop a systems approach based on an energy-landscape concept to differentiate interactions involving redox activities and conformational changes of proteins and nucleic acids interactions in multi-layered protein-D…
Physics-informed machine learning